Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.043; wR factor = 0.114; data-to-parameter ratio = 13.2.
In the title compound, C 22 H 24 FN 3 O 4 S, the cyclohexane ring adopts a chair conformation and the five-membered ring is essentially planar, with a maximum deviation of 0.040 (2) Å . The dihedral angles between the five-membered ring and the tolyl and fluorobenzene rings are 56.74 (12) and 89.88 (12) , respectively. The two terminal benzene rings make a dihedral angle of 63.53 (12) . The crystal structure displays intermolecular C-HÁ Á ÁO and N-HÁ Á ÁO hydrogen bonds. An intramolecular C-HÁ Á ÁO hydrogen bond also occurs.
Related literature
For the biological activity of related compounds, see: Cartwright et al. (2007) ; Collins (2000) ; Warshakoon et al. (2006) and for their pharmaceutical activity, see: Kiselyov et al. Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz þ 1; (ii) Àx; Ày þ 1; Àz; (iii) x þ 1; y; z; (iv) x À 1; y; z.
Data collection: CrysAlis PRO CCD (Oxford Diffraction, 2010 ); cell refinement: CrysAlis PRO CCD; data reduction: CrysAlis PRO RED (Oxford Diffraction, 2010); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and CAMERON (Watkin et al., 1993) ; software used to prepare material for publication: WinGX (Farrugia, 1999) . 
Comment
One of the challenges of medicinal chemistry is the promotion of structural diversity,which can be achieved by the attachment of pharmacophoric groups to significant molecular scaffolds in combinatorial chemistry. An example of such a process includes di-and tri-substituted hydantoins, which have been widely used in biological screenings, resulting in numerous pharmaceutical applications (Cartwright et al., 2007; Collins, 2000; Warshakoon et al., 2006) . Hydantoin analogues have shown versatile therapeutic applications and some of them have been approved as drugs. For example, fosphenytoin, as a sodium channel antagonist, is used for the treatment of epilepsy. Phenytoin has antiarrhythmic, anticonvulsant and antineuralgic activities. Ethotoin and mephenytoin both show anticonvulsant activity. Nilutamide is used in the treatment of prostate cancer (Kiselyov et al., 2006; Sakthivel & Cook, 2005; Eldrup et al., 2004; Bamford et al., 2005; Puerstinger et al., 2006) .
C 22 H 24 FN 3 O 4 S, contains just one molecule (Fig. 1) . The cyclohexane ring adopts a chair conformation and the fivemembered ring is essentially planar, with a maximum deviation from planarity of 0.040 (2) Å, for atom C18. The dihedral angles between the five-membered ring and the (C25-C30) and (C10-C15) rings are 56.74 (12)° and 89.88 (12)°, respectively. The two terminal aromatic rings make a dihedral angle of 63.53 (12)°. The crystal structure displays intermolecular N7-H7···O4, N9-H9···O6, C12-H12···O3 and C31-H31C···O5 hydrogen bonds (Table 1) ; an intramolecular C31-H31A···O6 hydrogen bond is also observed. The packing of the molecules in the title structure is depicted in Fig. 2. A short contact of 2.04 Å was observed for H9···H31A.
Experimental
A mixture of tert-butyl (4-oxocyclohexyl)carbamate (2 g, 9.37 mmol) and ammonium carbonate (1.08 g, 11.2 mmol) were taken up in ethanol and water, respectively. A solution of sodium cyanide (2 g, 9.37 mmol) in water (6 ml) was added dropwise and the reaction mixture was stirred at RT for 24 hrs. A mixture of anhydrous potassium carbonate (1.28 g, 9.31 mmol) and 1-(bromomethyl)-4-fluorobenzene (1.30 g, 6.9 mmol) in DMF (20ml) was refluxed and the solid was filtered, washed with water and dried in vacuum to yield hydantoin. The tert-butyl dicarbonate (BOC) was de-protected using dioxane-HCl and rendered basic to obtain the free amine. A mixture of the product (0.2 g, 0.686 mmol), triethylamine (0.083 g, 0.82 mmol) and sulfonyl chloride (0.083 g, 0.617 mmol) in dichloromethane (10ml) was stirred at room temperature. After completion of the reaction (checked by TLC) the product was concentrated in vacuum to give the title compound (160 mg, 53%), which was recrystalized using 1:1 hexane: ethyl acetate as solvent. 
N-[3-(4-Fluorobenzyl)-2,4-dioxo-1,3-diazaspiro[4.5]dec-8-yl]-2-methylbenzenesulfonamide
Crystal data Symmetry codes: (i) −x+1, −y+1, −z+1; (ii) −x, −y+1, −z; (iii) x+1, y, z; (iv) x−1, y, z.
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